Cabaletta Bio, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States · Nasdaq: CABA
Cabaletta Bio, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker CABA. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2019.
Cabaletta Bio at a glance
What does Cabaletta Bio do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $50 million sold (2019).
Frequently asked questions about Cabaletta Bio
Where is Cabaletta Bio headquartered?
Cabaletta Bio, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Cabaletta Bio do?
Cabaletta Bio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Cabaletta Bio a public company?
Yes. Cabaletta Bio, Inc. trades on Nasdaq under the ticker CABA.
When was Cabaletta Bio founded?
The earliest incorporation on record for Cabaletta Bio, Inc. is in 2017, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.